Ειδήσεις: NOVO NORDISK | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 15:23 forbes.com

Wegovy Subscription Launched—Will Save Users Up To $1,200 Per Year, Novo Nordisk Says

Wegovy Novo Nordisk subscription program cost savings weight loss injections

31/03 14:36 investing.com

Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US

Novo Nordisk Wegovy discounted subscriptions self‑pay patients US market weight‑loss medication

27/03 15:25 statnews.com

STAT+: Pharmalittle: We’re reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more

Novo Nordisk FDA gene therapy consumer focus personalized medicine biotech

26/03 07:26 bloomberg.com

Novo Chairman Faces Testy Investors With Little Progress So Far

Novo Nordisk Chairman Investors Annual Meeting Boardroom Coup Lars Rebien Sorensen

24/03 15:16 yahoo.com

Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer

Novo Nordisk GLP‑1 drug approval diabetes treatment market competition innovation

23/03 09:22 google.com

Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy - Reuters

Indian generics Ozempic Wegovy Novo Nordisk diabetes obesity

19/03 23:16 washingtonexaminer.com

FDA greenlights higher-dose GLP-1 obesity shots

FDA Wegovy GLP‑1 obesity weight loss higher dose

19/03 20:42 marketwatch.com

A high dose of Wegovy helped people lose 21% of their weight. It was just approved.

Wegovy weight loss GLP‑1 Novo Nordisk Lilly obesity treatment

19/03 20:19 thehill.com

FDA approves higher dose of Wegovy

FDA Wegovy semaglutide weight loss higher dose Novo Nordisk

19/03 20:19 thehill.com

FDA approves higher dose of Wegovy

FDA Wegovy semaglutide weight loss higher dose Novo Nordisk

Loading...